Ngā hua rapu - Heinz‐Josef Lenz

Whakamahine hua
  1. 1
    Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways as Therapeutic Targets for Colorectal Cancer

    Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways as Therapeutic Targets for Colorectal Cancer mā Thomas Winder, Heinz‐Josef Lenz

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Safely targeting cancer stem cells via selective catenin coactivator antagonism

    Safely targeting cancer stem cells via selective catenin coactivator antagonism mā Heinz‐Josef Lenz, Michaël Kahn

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Explaining the Unexplainable: EGFR Antibodies in Colorectal Cancer

    Explaining the Unexplainable: EGFR Antibodies in Colorectal Cancer mā Axel Grothey, Heinz‐Josef Lenz

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor

    Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor mā Ana Sebio, Heinz‐Josef Lenz

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Biomarker in Colorectal Cancer

    Biomarker in Colorectal Cancer mā Marta Schirripa, Heinz‐Josef Lenz

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Chemotherapy with Targeted Agents for the Treatment of Metastatic Colorectal Cancer

    Chemotherapy with Targeted Agents for the Treatment of Metastatic Colorectal Cancer mā Claus‐Henning Köhne, Heinz‐Josef Lenz

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    TAS-102, a novel antitumor agent: A review of the mechanism of action

    TAS-102, a novel antitumor agent: A review of the mechanism of action mā Heinz‐Josef Lenz, Sebastian Stintzing, Fotios Loupakis

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    The potential of targeting Wnt/β-catenin in colon cancer

    The potential of targeting Wnt/β-catenin in colon cancer mā Ana Sebio, Michaël Kahn, Heinz‐Josef Lenz

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions

    Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions mā Francesca Battaglin, Madiha Naseem, Alberto Puccini, Heinz‐Josef Lenz

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Comparative effectiveness of screening strategies for colorectal cancer

    Comparative effectiveness of screening strategies for colorectal cancer mā Afsaneh Barzi, Heinz‐Josef Lenz, David I. Quinn, Sarmad Sadeghi

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Molecular Pathways: Estrogen Pathway in Colorectal Cancer

    Molecular Pathways: Estrogen Pathway in Colorectal Cancer mā Afsaneh Barzi, Annika Lenz, Melissa J. LaBonte, Heinz‐Josef Lenz

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes

    Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes mā Sebastian Stintzing, Sabine Tejpar, Peter Gibbs, Lars Thiebach, Heinz‐Josef Lenz

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Molecular Pathways: Cachexia Signaling—A Targeted Approach to Cancer Treatment

    Molecular Pathways: Cachexia Signaling—A Targeted Approach to Cancer Treatment mā Yuji Miyamoto, Diana L. Hanna, Wu Zhang, Hideo Baba, Heinz‐Josef Lenz

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Reprogramming Exosomes as Nanoscale Controllers of Cellular Immunity

    Reprogramming Exosomes as Nanoscale Controllers of Cellular Immunity mā Qinqin Cheng, Xiaojing Shi, Menglu Han, Goar Smbatyan, Heinz‐Josef Lenz, Yong Zhang

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignancies

    Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignancies mā Alberto Puccini, Francesca Battaglin, Maria Laura Iaia, Heinz‐Josef Lenz, Mohamed E. Salem

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    All You Need to Know About <i>DPYD</i> Genetic Testing for Patients Treated With Fluorouracil and Capecitabine: A Practitioner-Friendly Guide

    All You Need to Know About <i>DPYD</i> Genetic Testing for Patients Treated With Fluorouracil and Capecitabine: A Practitioner-Friendly Guide mā Federico Innocenti, Sarah Mills, Hanna K. Sanoff, Joseph Ciccolini, Heinz‐Josef Lenz, G. Milano

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Eliciting anti-cancer immunity by genetically engineered multifunctional exosomes

    Eliciting anti-cancer immunity by genetically engineered multifunctional exosomes mā Qinqin Cheng, Zhefu Dai, Goar Smbatyan, Alan L. Epstein, Heinz‐Josef Lenz, Yong Zhang

    I whakaputaina 2022
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement

    Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement mā Roderich E. Schwarz, Jordan Berlin, Heinz Josef Lenz, Bernard Nordlinger, Laura Rubbia‐Brandt, Michael A. Choti

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Inhibition of dUTPase Induces Synthetic Lethality with Thymidylate Synthase–Targeted Therapies in Non–Small Cell Lung Cancer

    Inhibition of dUTPase Induces Synthetic Lethality with Thymidylate Synthase–Targeted Therapies in Non–Small Cell Lung Cancer mā Peter M. Wilson, Melissa J. LaBonte, Heinz‐Josef Lenz, Philip C. Mack, Robert D. Ladner

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Molecular insight of regorafenib treatment for colorectal cancer

    Molecular insight of regorafenib treatment for colorectal cancer mā Hiroyuki Arai, Francesca Battaglin, Jingyuan Wang, Jae Ho Lo, Shivani Soni, Wu Zhang, Heinz‐Josef Lenz

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: